A postdoctoral position is available immediately for a highly motivated 
candidate in the Institute of Human Virology http://www.ihv.org at the 
University Of Maryland School Of Medicine (UMSOM; 
http://medschool.umaryland.edu/ in Baltimore, Maryland. IHV is the first center 
in the United States - perhaps the world - to combine the disciplines of basic 
science, epidemiology and clinical research in a concerted effort to speed the 
discovery of diagnostics and therapeutics for a wide variety of chronic and 
deadly viral and immune disorders - most notably HIV, the cause of AIDS. 
Our laboratory focuses on the molecular basis of function of proteins involved 
in the anti-HIV-1 immune responses, human immune defense in general, and cancer 
prevention (http://www.ihv.org/research/bio_recognition). Successful candidate 
will utilize the established high-throughput structural biology platform and 
biochemical/biophysical techniques to study novel targets on HIV-1 Env that are 
exposed during viral attachement/entry and are exclusively responsible for Fc 
mediated effector function (ADCC). Studies will focus on structural 
characterization and epitope definition of ADCC-mediating anti-HIV-1 Env mAbs, 
as well as the structure-based studies guiding development of protein-based 
therapeutics and novel vaccines. 
The position requires a Ph.D. in biochemistry, molecular biology, or a closely 
related discipline with practical experience in molecular biology and protein 
science techniques including surface plasmon resonance, isothermal titration 
calorimetry and X-ray crystallography. Candidates need to be highly motivated 
individuals who enjoy working as part of a young, dynamic, collaborative and 
multidisciplinary team. Excellent oral and written communication skills and 
good presentation skills are essential. 
Interested parties should submit electronically a CV, a statement of research 
interests and previous experience, and contact information of three references 
to mpazg...@ihv.umaryland.edu Review of completed applications will begin 
immediately. 

Reply via email to